Sign Up to like & get
recommendations!
1
Published in 2018 at "Cell metabolism"
DOI: 10.1016/j.cmet.2018.11.010
Abstract: Heart failure and renal disease remain significant complications in people with type 2 diabetes (T2D). Recent outcome studies with sodium-glucose cotransporter-2 (SGLT2) inhibitors have provided increasing insights, with the latest reporting trial DECLARE-TIMI 58 (Wiviott…
read more here.
Keywords:
cardio renal;
renal disease;
victory cardio;
declare victory ... See more keywords